Walleye Capital LLC Biotechnology

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
NVO
Novo Nordisk A S
PUT
$13.8 Million
116K
Q3 2024
Added 37.9%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$11.2 Million
10.7K
Q3 2024
Added 48.31%
BNTX
Bio N Tech Se
PUT
$10.7 Million
90.2K
Q3 2024
Reduced 82.13%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$8.52 Million
8.1K
Q3 2024
Added 48.31%
VRTX
Vertex Pharmaceuticals Inc
CALL
$8.23 Million
17.7K
Q3 2024
Added 93.21%
NVO
Novo Nordisk A S
CALL
$6.85 Million
57.5K
Q3 2024
Added 37.9%
VRTX
Vertex Pharmaceuticals Inc
PUT
$5.95 Million
12.8K
Q3 2024
Added 93.21%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$5.34 Million
19.4K
Q3 2024
Reduced 94.81%
MRNA
Moderna, Inc.
PUT
$4.9 Million
73.3K
Q3 2024
Added 51.66%
UTHR
United Therapeutics Corp
PUT
$4.84 Million
13.5K
Q3 2024
Reduced 84.41%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$4.24 Million
15.4K
Q3 2024
Reduced 94.81%
SRPT
Sarepta Therapeutics, Inc.
CALL
$3.35 Million
26.8K
Q3 2024
Reduced 72.28%
INSM
Insmed Inc
CALL
$3.18 Million
43.6K
Q3 2024
Added 38.21%
VKTX
Viking Therapeutics, Inc.
CALL
$3.09 Million
48.8K
Q3 2024
Added 26.76%
BNTX
Bio N Tech Se
CALL
$2.83 Million
23.8K
Q3 2024
Reduced 82.13%
VKTX
Viking Therapeutics, Inc.
PUT
$2.72 Million
42.9K
Q3 2024
Added 26.76%
MRNA
Moderna, Inc.
CALL
$2.17 Million
32.4K
Q3 2024
Added 51.66%
SRPT
Sarepta Therapeutics, Inc.
PUT
$2.06 Million
16.5K
Q3 2024
Reduced 72.28%
NTLA
Intellia Therapeutics, Inc.
PUT
$2 Million
97.5K
Q3 2024
Added 28.78%
INSM
Insmed Inc
PUT
$1.91 Million
26.2K
Q3 2024
Added 38.21%
UTHR
United Therapeutics Corp
CALL
$1.68 Million
4.7K
Q3 2024
Reduced 84.41%
BMRN
Biomarin Pharmaceutical Inc
PUT
$1.68 Million
23.9K
Q3 2024
Added 305.61%
EXEL
Exelixis, Inc.
CALL
$1.28 Million
49.4K
Q3 2024
New holding
TECH
Bio Techne Corp
PUT
$1.13 Million
14.1K
Q3 2024
Reduced 94.82%
LEGN
Legend Biotech Corp
PUT
$1.11 Million
22.7K
Q3 2024
Reduced 97.78%
BPMC
Blueprint Medicines Corp
PUT
$1.08 Million
11.7K
Q3 2024
Reduced 66.66%
LEGN
Legend Biotech Corp
CALL
$930,000
19.1K
Q3 2024
Reduced 97.78%
NTLA
Intellia Therapeutics, Inc.
CALL
$920,000
44.8K
Q3 2024
Added 28.78%
INCY
Incyte Corp
CALL
$832,000
12.6K
Q3 2024
Reduced 98.84%
IONS
Ionis Pharmaceuticals Inc
CALL
$813,000
20.3K
Q3 2024
Added 26.82%
TGTX
Tg Therapeutics, Inc.
CALL
$704,000
30.1K
Q3 2024
New holding
AGIO
Agios Pharmaceuticals, Inc.
CALL
$701,000
15.8K
Q3 2024
Added 623.36%
BPMC
Blueprint Medicines Corp
CALL
$628,000
6.8K
Q3 2024
Reduced 66.66%
FOLD
Amicus Therapeutics, Inc.
CALL
$625,000
58.6K
Q3 2024
Added 3381.53%
SAVA
Cassava Sciences Inc
PUT
$588,000
20K
Q3 2024
New holding
ROIV
Roivant Sciences Ltd.
CALL
$580,000
50.3K
Q1 2024
Reduced 99.97%
NVAX
Novavax Inc
PUT
$579,000
45.9K
Q3 2024
Reduced 84.78%
BBIO
Bridge Bio Pharma, Inc.
CALL
$527,000
20.7K
Q2 2024
Added 254.27%
ZLAB
Zai Lab LTD
CALL
$494,000
20.5K
Q3 2024
Reduced 84.55%
TGTX
Tg Therapeutics, Inc.
PUT
$491,000
21K
Q3 2024
New holding
AXSM
Axsome Therapeutics, Inc.
PUT
$485,000
5.4K
Q3 2024
Reduced 38.52%
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$483,000
8.7K
Q3 2024
Reduced 87.42%
ARGX
Argenx Se
PUT
$433,000
800
Q3 2024
Reduced 88.43%
HALO
Halozyme Therapeutics, Inc.
PUT
$429,000
7.5K
Q3 2024
Reduced 98.87%
KRYS
Krystal Biotech, Inc.
CALL
$381,000
2.1K
Q3 2024
New holding
CRSP
Crispr Therapeutics Ag
CALL
$375,000
8K
Q3 2024
Reduced 44.97%
AUPH
Aurinia Pharmaceuticals Inc.
CALL
$371,000
50.7K
Q1 2024
New holding
FOLD
Amicus Therapeutics, Inc.
PUT
$369,000
34.6K
Q3 2024
Added 3381.53%
CRSP
Crispr Therapeutics Ag
PUT
$324,000
6.9K
Q3 2024
Reduced 44.97%
Filter Shares Options
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email